Endocannabinoid control of food intake and energy balance (Q36108722)

12 August 2017

1 reference

title

Endocannabinoid control of food intake and energy balance (English)

1 reference

12 August 2017

0 references

Vincenzo Di Marzo

1

0 references

author name string

Isabel Matias

series ordinal

2

1 reference

PubMed ID

15856067

12 August 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

12 August 2017

1 reference

12 August 2017

8

1 reference

12 August 2017

585-589

1 reference

12 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/nn1457

12 August 2017

0 references

cites work

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

1 reference

7 January 2021

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

7 January 2021

The cannabinoid receptors.

1 reference

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

7 January 2021

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

7 January 2021

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

1 reference

7 January 2021

Molecular characterization of a phospholipase D generating anandamide and its congeners

1 reference

7 January 2021

Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain

1 reference

7 January 2021

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

1 reference

7 January 2021

Brain monoglyceride lipase participating in endocannabinoid inactivation

1 reference

7 January 2021

The endocannabinoid system and its therapeutic exploitation

1 reference

7 January 2021

Hyperphagia in pre-fed rats following oral delta9-THC.

1 reference

7 January 2021

Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors

1 reference

7 January 2021

Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice.

1 reference

7 January 2021

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

7 January 2021

Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

1 reference

7 January 2021

Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats

1 reference

7 January 2021

Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine

1 reference

7 January 2021

Effects of the cannabinoid antagonists AM281 and AM630 on deprivation-induced intake in Lewis rats.

1 reference

7 January 2021

SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization

1 reference

7 January 2021

Leptin-regulated endocannabinoids are involved in maintaining food intake

1 reference

7 January 2021

Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats

1 reference

7 January 2021

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

1 reference

7 January 2021

The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin.

1 reference

7 January 2021

The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats

1 reference

7 January 2021

Behavioral mechanisms underlying inhibition of food-maintained responding by the cannabinoid receptor antagonist/inverse agonist SR141716A.

1 reference

7 January 2021

The cannabinoid CB1 receptor antagonist SR141716A reduces appetitive and consummatory responses for food.

1 reference

7 January 2021

Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716.

1 reference

7 January 2021

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

1 reference

7 January 2021

Endocannabinoids and the regulation of body fat: the smoke is clearing

1 reference

7 January 2021

Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism.

1 reference

7 January 2021

Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716

1 reference

7 January 2021

Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice

1 reference

7 January 2021

Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake.

1 reference

7 January 2021

The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol

1 reference

7 January 2021

Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior

1 reference

7 January 2021

Synergistic efects of opioid and cannabinoid antagonists on food intake

1 reference

7 January 2021

The cannabinoid receptor antagonist SR�141716 attenuates overfeeding induced by systemic or intracranial morphine

1 reference

7 January 2021

Synergistic effects of cannabinoid inverse agonist AM251 and opioid antagonist nalmefene on food intake in mice

1 reference

7 January 2021

The endocannabinoid-CB(1) receptor system in pre- and postnatal life

1 reference

7 January 2021

Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period

1 reference

7 January 2021

Trick or treat from food endocannabinoids?

1 reference

7 January 2021

A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.

1 reference

7 January 2021

Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin.

1 reference

7 January 2021

Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats.

1 reference

7 January 2021

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

1 reference

7 January 2021

Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice

1 reference

7 January 2021

The anti-obesity effect of rimonabant is associated with an improved serum lipid profile

1 reference

7 January 2021

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

1 reference

7 January 2021

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice

1 reference

7 January 2021

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

1 reference

7 January 2021

Adiponectin acts in the brain to decrease body weight.

1 reference

7 January 2021

Rapid tolerance to the intestinal prokinetic effect of cannabinoid CB1 receptor antagonist, SR 141716 (Rimonabant).

1 reference

7 January 2021

Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets

1 reference

7 January 2021

Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain

1 reference

7 January 2021

Effect of maternal under-nutrition on pup body weight and hypothalamic endocannabinoid levels

1 reference

7 January 2021

n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice

1 reference

7 January 2021

Inverse agonism and neutral antagonism at cannabinoid CB1 receptors

1 reference

7 January 2021

Leptin activates the anandamide hydrolase promoter in human T lymphocytes through STAT3.

1 reference

7 January 2021

Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH).

1 reference

7 January 2021

Identifiers

DOI

10.1038/NN1457

1 reference

12 August 2017

1 reference

PubMed ID

15856067